BCYC
Price
$7.16
Change
+$0.19 (+2.73%)
Updated
Sep 5 closing price
Capitalization
483.07M
54 days until earnings call
RLAY
Price
$4.12
Change
+$0.12 (+3.00%)
Updated
Sep 5 closing price
Capitalization
710.34M
60 days until earnings call
Interact to see
Advertisement

BCYC vs RLAY

Header iconBCYC vs RLAY Comparison
Open Charts BCYC vs RLAYBanner chart's image
Bicycle Therapeutics
Price$7.16
Change+$0.19 (+2.73%)
Volume$177.42K
Capitalization483.07M
Relay Therapeutics
Price$4.12
Change+$0.12 (+3.00%)
Volume$2.03M
Capitalization710.34M
BCYC vs RLAY Comparison Chart in %
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. RLAY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a StrongBuy and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BCYC: $7.16 vs. RLAY: $4.12)
Brand notoriety: BCYC and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 66% vs. RLAY: 99%
Market capitalization -- BCYC: $483.07M vs. RLAY: $710.34M
BCYC [@Biotechnology] is valued at $483.07M. RLAY’s [@Biotechnology] market capitalization is $710.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • RLAY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BCYC and RLAY are a good buy in the short-term.

Price Growth

BCYC (@Biotechnology) experienced а -2.98% price change this week, while RLAY (@Biotechnology) price change was +14.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 30, 2025.

RLAY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($710M) has a higher market cap than BCYC($483M). RLAY YTD gains are higher at: 0.000 vs. BCYC (-48.857). BCYC has higher annual earnings (EBITDA): -240.81M vs. RLAY (-338.15M). BCYC has more cash in the bank: 721M vs. RLAY (657M). BCYC has less debt than RLAY: BCYC (7.2M) vs RLAY (34.2M). BCYC has higher revenues than RLAY: BCYC (19.3M) vs RLAY (8.36M).
BCYCRLAYBCYC / RLAY
Capitalization483M710M68%
EBITDA-240.81M-338.15M71%
Gain YTD-48.8570.000-
P/E RatioN/AN/A-
Revenue19.3M8.36M231%
Total Cash721M657M110%
Total Debt7.2M34.2M21%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCRLAY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYESX189.35N/A
N/A
Rydex Energy Services A
FASDX17.87N/A
N/A
Fidelity Advisor Strategic Div & Inc A
FSCPX70.34N/A
N/A
Fidelity Select Consumer Discret Port
MAGRX32.19N/A
N/A
BlackRock Natural Resources Instl
MXJVX10.44N/A
N/A
Empower International Value Instl

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+2.73%
RPTX - BCYC
52%
Loosely correlated
N/A
XNCR - BCYC
50%
Loosely correlated
+2.15%
RLAY - BCYC
47%
Loosely correlated
+3.00%
RCUS - BCYC
43%
Loosely correlated
+5.45%
IDYA - BCYC
41%
Loosely correlated
+5.15%
More